April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
The Role of Humphrey Matrix Testing in the Long Term Follow Up of Type 1 Diabetes
Author Affiliations & Notes
  • Mariacristina Parravano
    Ophthalmology, Fondazione G.B. Bietti-IRCCS, Rome, Italy
  • Francesco Oddone
    Ophthalmology, Fondazione G.B. Bietti-IRCCS, Rome, Italy
  • Barbara Boccassini
    Ophthalmology, Fondazione G.B. Bietti-IRCCS, Rome, Italy
  • Paola Giorno
    Ophthalmology, Fondazione G.B. Bietti-IRCCS, Rome, Italy
  • Francesca Berardo
    Ophthalmology, Fondazione G.B. Bietti-IRCCS, Rome, Italy
  • Patrizia Borboni
    Dipartimento di Medicina Interna, Cattedra di Endocrinologia, Università di Roma Tor Vergata, Rome, Italy
  • Monica Varano
    Ophthalmology, Fondazione G.B. Bietti-IRCCS, Rome, Italy
  • Footnotes
    Commercial Relationships  Mariacristina Parravano, None; Francesco Oddone, None; Barbara Boccassini, None; Paola Giorno, None; Francesca Berardo, None; Patrizia Borboni, None; Monica Varano, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 1289. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mariacristina Parravano, Francesco Oddone, Barbara Boccassini, Paola Giorno, Francesca Berardo, Patrizia Borboni, Monica Varano; The Role of Humphrey Matrix Testing in the Long Term Follow Up of Type 1 Diabetes. Invest. Ophthalmol. Vis. Sci. 2011;52(14):1289.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : to investigate the role of frequency doubling perimetry (Humphrey Matrix; Carl Zeiss Meditec Inc., Dublin, CA, USA) in the long term follow up in subjects with type 1 diabetes mellitus (DM1) without any signs of retinal vasculopathy, and to investigate the relationship between both functional and structural retinal parameters and metabolic control.

Methods: : consecutive subjects with DM1, with no sign of retinal vasculopathy at baseline, have been followed for long term in this prospective cross-sectional clinical study. Functional testing included Humphrey Matrix perimetry (30-2 threshold program) and white-on-white Humphrey visual field perimetry (HFA, 30-2 SITA standard), while retinal nerve fibre layer (RNFL) thickness was measured by scanning laser polarimetry with variable corneal birefringence compensator (GDx VCC).

Results: : data from 19 eyes of 19 subjects with DM1 (age 39,5±9,2; 10 males/9 females) were analyzed. Mean follow up time was 59,2±5,4 months (range 49-65). Mean diabetes duration was 17,4±13 years. Mean HbA1c was 7,42±1,22%. 10/19 patients used insulin microinfusor. Only one patient showed a progression to non proliferative diabetic retinopathy during the follow up. Similar values were found between baseline and the end of follow up both for HFA mean deviation (MD: -2,20±3,44 vs -1,63±2,47; p=0,14) and pattern standard mean deviation (PSD: 2,50±1,71 vs 2,28±1,36; p=0,31). Matrix MD was found to be similar between baseline and the end of follow up (-1,06±3,62 vs -1,24±2,99; p=0,65). A statistically significant difference was found for Matrix PSD between baseline and the end of follow up (2.76±0.59 vs 3.1±0.68; p= 0.0078). Morphological parameters were not changed during follow up. A significant relationship was found between HbA1c levels and changes from baseline of Matrix PSD (R2 0,29, p=0.02).

Conclusions: : the localized reduction of retinal sensitivity, as measured by Matrix, seem to be the only parameter that showed a significant change during long term follow up in our population of DM1 patients.

Keywords: perimetry • diabetes • nerve fiber layer 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×